Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Urology

• Publication date

  1997-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0090-4295(97)00408-1PMID 9426741
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synergistic enhancement by interleukin-1 α of cisplatin-mediated antitumor activity in RIF-1 tumor-bearing C3H/HeJ mice

  2004cited by this paper
• Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system.

  1997cited by this paper
• Cyclin-dependent kinase inhibitor p27 as a mediator of the G1-S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells.

  1996cited by this paper
• The role of vitamin D in normal prostate growth and differentiation.

  1996cited by this paper
• 20-epi-vitamin D3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines.

  1995cited by this paper
• Chemopreventive activity of tamoxifen, N-(4-hydroxyphenyl)retinamide, and the vitamin D analogue Ro24-5531 for androgen-promoted carcinomas of the rat seminal vesicle and prostate.

  1995cited by this paper
• Structure-function relationships in the vitamin D endocrine system.

  1995cited by this paper
• Antiproliferative effects in vitro and in vivo of 1,25-dihydroxyvitamin D3 and a vitamin D3 analog in a squamous cell carcinoma model system

  1995cited by this paper
• Growth inhibition of HT-29 human colon cancer cells by analogues of 1,25-dihydroxyvitamin D3.

  1994cited by this paper
• Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells.

  1994cited by this paper
• A dual block to cell cycle progression in HL60 cells exposed to analogues of vitamin D,

  1994cited by this paper
• Human prostate cancer cells: inhibition of proliferation by vitamin D analogs.

  1994cited by this paper
• Cell cycle control by steroid hormones.

  1994cited by this paper
• Correspondence re: E. H. Corder et al., Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiol., Biomarkers & Prev., 2: 467-472, 1993.

  1994cited by this paper
• Cell cycle control by steroid hormones.

  1994cited by this paper
• Human prostate cancer cells: inhibition of proliferation by vitamin D analogs.

  1994cited by this paper
• Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines.

  1993cited by this paper
• Vitamin D and prostate cancer: a prediagnostic study with stored sera.

  1993cited by this paper
• Vitamin D, calcium, and epidermal differentiation.

  1993cited by this paper
• The human prostatic carcinoma cell line LNCaP expresses biologically active, specific receptors for 1 alpha,25-dihydroxyvitamin D3.

  1992cited by this paper
• Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation

  1992cited by this paper
• Effects of synthetic vitamin D analogues on breast cancer cell proliferation in vivo and in vitro.

  1992cited by this paper
• Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis).

  1990cited by this paper
• Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis).

  1990cited by this paper
• Novel vitamin D analogs that modulate leukemic cell growth and differentiation with little effect on either intestinal calcium absorption or bone mobilization.

  1989cited by this paper
• The role of the vitamin D endocrine system in health and disease.

  1989cited by this paper
• High-dose vitamin D therapy: indications, benefits and hazards.

  1989cited by this paper
• Establishment and characterization of seven dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers

  1987cited by this paper
• Cell cycle sensitivity of HL-60 cells to the differentiation-inducing effects of 1-alpha,25-dihydroxyvitamin D3.

  1985cited by this paper
• 1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells

  1984cited by this paper
• A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis.

  1983cited by this paper
• Fundamentals of Clinical Chemistry

  1970cited by this paper

• Cancer Reversion Therapy: Prospects, Progress and Future Directions

  2025cites this paper
• Immunomodulatory role of vitamin D and emerging immunotherapies in hepatocellular carcinoma

  2025cites this paper
• Vitamin D‐induced mechanisms in cancer prevention and therapy: Recent advances and future opportunities

  2025cites this paper
• Vitamin D in Cancer Prevention and Treatment: A Review of Epidemiological, Preclinical, and Cellular Studies

  2024cites this paper
• Vitamin D and colorectal cancer - A practical review of the literature.

  2022cites this paper
• Vitamin D3, arsenic trioxide, or combination therapy for acute promyelocytic leukemia

  2022cites this paper
• Impact of DNA methylation on ADME gene expression, drug disposition, and efficacy

  2022cites this paper
• Pharmacokinetic Estimation Models-based Approach to Predict Clinical Implications for CYP Induction by Calcitriol in Human Cryopreserved Hepatocytes and HepaRG Cells

  2021cites this paper
• Colorectal Cancer Screening Outcomes of 2412 Prostate Cancer Patients Considered for Carbon Ion Radiotherapy

  2021cites this paper
• New Roles for Vitamin D Superagonists: From COVID to Cancer

  2021cites this paper
• Perifosine and vitamin D combination induces apoptotic and non-apoptotic cell death in endometrial cancer cells

  2020cites this paper
• Vitamin D Signaling in Inflammation and Cancer: Molecular Mechanisms and Therapeutic Implications

  2020cites this paper
• Effect of vitamin D on malignant behavior of non-small cell lung cancer cells.

  2020cites this paper
• Regulation of the Immune Balance During Allogeneic Hematopoietic Stem Cell Transplantation by Vitamin D

  2019cites this paper
• Therapeutic targets of vitamin D receptor ligands and their pharmacokinetic effects by modulation of transporters and metabolic enzymes

  2019cites this paper
• Overview of vitamin D actions in cancer

  2018cites this paper
• Modelling human prostate cancer: Rat models

  2018cites this paper
• DOX-Vit D, a Novel Doxorubicin Delivery Approach, Inhibits Human Osteosarcoma Cell Proliferation by Inducing Apoptosis While Inhibiting Akt and mTOR Signaling Pathways

  2018cites this paper
• Antimicrobial peptides: Role in human disease and potential as immunotherapies

  2017cites this paper
• Vitamin D Signaling Modulators in Cancer Therapy.

  2016cites this paper
• Phase IIa, randomized placebo-controlled trial of single high dose cholecalciferol (vitamin D3) and daily Genistein (G-2535) versus double placebo in men with early stage prostate cancer undergoing prostatectomy.

  2016cites this paper
• The PI3K/AKT pathway in the pathogenesis of prostate cancer.

  2016cites this paper
• Phosphorylation of Human Retinoid X Receptor α at Serine 260 Impairs Its Subcellular Localization, Receptor Interaction, Nuclear Mobility, and 1α,25-Dihydroxyvitamin D3-dependent DNA Binding in Ras-transformed Keratinocytes*

  2016cites this paper
• Vitamin D in Prostate Cancer.

  2016cites this paper
• LEIOMYOMAS PREVALENCE IN AFRICAN AMERICANS

  2015cites this paper
• 19-Norvitamin D analogs for breast cancer therapy.

  2015cites this paper
• Association between Plasma 25-Hydroxyvitamin D, Ancestry and Aggressive Prostate Cancer among African Americans and European Americans in PCaP

  2015cites this paper
• Role of vitamin D in uterine fibroid biology.

  2015cites this paper
• Vitamin D and Related Genes, Race and Prostate Cancer Aggressiveness

  2015cites this paper
• Vitamin D in cancer: effects of pharmaceutical drugs on the vitamin D pharmacokinetics

  2014cites this paper
• Early Growth Inhibition Is Followed by Increased Metastatic Disease with Vitamin D (Calcitriol) Treatment in the TRAMP Model of Prostate Cancer

  2014cites this paper
• Randomized Trial of the Effects of Vitamin D on Tissue Vitamin D Metabolites and on Prostate Cancer Pathology

  2014influential citation
• CYP24A1 as a potential target for cancer therapy.

  2014cites this paper
• Vitamin D and miRNAs in cancer.

  2014cites this paper
• Phase I Safety and Pharmacodynamic of Inecalcitol, a Novel VDR Agonist with Docetaxel in Metastatic Castration-Resistant Prostate Cancer Patients

  2014cites this paper
• THE NATURAL FLAVONOID LUTEOLIN INDUCES APOPTOSIS IN COLON CANCER CELLS BY DYSREGULATING THE SPHINGOLIPID RHEOSTAT

  2014cites this paper
• Enhanced Differentiation of Stromal Cells and Embryonic Stem Cells with Vitamin D3

  2013cites this paper
• Vitamin D receptor activity is differentially affected by the co-regulator Hic-5 in prostate cancer and stromal cells

  2013cites this paper
• Murine Models of Prostate Cancer

  2013cites this paper
• Anticancer steroids: linking natural and semi-synthetic compounds.

  2013cites this paper
• Vitamin D and cancer:present status and future prospects

  2013cites this paper
• Impact of Calcitriol on Human Squamous and Transitional Bladder Carcinoma Cell Lines

  2013cites this paper
• Enhanced Differentiation of Stromal Cells and Embryonic Stem Cells with Vitamin D 3 E World

  2013cites this paper
• Profile of vitamin D levels among African men presenting for prostate cancer treatment at Kenyatta national hospital

  2013cites this paper
• 1498-1507 Varad 399

  2013cites this paper
• Progesterone Enhances Calcitriol Antitumor Activity by Upregulating Vitamin D Receptor Expression and Promoting Apoptosis in Endometrial Cancer Cells

  2013cites this paper
• Vitamin D in the prevention and treatment of pancreatic cancer

  2013cites this paper
• A liquid chromatography/electrospray ionization tandem mass spectrometric method for the quantification of calcitriol in human plasma: application to pharmacokinetic study in human subjects

  2013cites this paper
• Tumor Suppressor microRNAs, miR-100 and -125b, Are Regulated by 1,25-dihydroxyvitamin D in Primary Prostate Cells and in Patient Tissue

  2013cites this paper
• Vitamin D and Prostate Cancer

  2013cites this paper
• Prognostic significance of genetic polymorphisms on prostate-specific antigen recurrence after a radical prostatectomy

  2012cites this paper
• Steroid Receptors in Renal Cell Carcinoma

  2012cites this paper
• Suppressive Effect of 19-nor-1α-25-Dihydroxyvitamin D2 on Gastric Cancer Cells and Peritoneal Metastasis Model

  2012cites this paper
• Vitamin D and Intimal Hyperplasia in Coronary Artery Disease

  2012cites this paper
• 1α,25‐dihydroxyvitamin D3 enhances fast‐myosin heavy chain expression in differentiated C2C12 myoblasts

  2012cites this paper
• Vitamin D and Cancer

  2012cites this paper
• High-Dose Calcitriol, Docetaxel and Zoledronic Acid in Patients with Castration-Resistant Prostate Cancer: A Phase II Study

  2012cites this paper
• Current management of prostate cancer: dilemmas and trials.

  2012cites this paper
• Effect of 25‐hydroxyvitamin D3 and 1 α,25 dihydroxyvitamin D3 on differentiation and apoptosis of human osteosarcoma cell lines

  2012cites this paper
• Investigation of Novel Progression-related Methylation Events and HOXD Genes in Prostate Cancer

  2012cites this paper
• The Anti-cancer Actions of Vitamin D Anti-Cancer Agents in Medicinal Chemistry

  2012cites this paper
• The anti-cancer actions of vitamin D.

  2012cites this paper
• Potent 19-norvitamin D analogs for prostate and liver cancer therapy.

  2012cites this paper
• The role of vitamin D in cancer prevention and treatment.

  2012cites this paper
• Identification of microRNA-98 as a Therapeutic Target Inhibiting Prostate Cancer Growth and a Biomarker Induced by Vitamin D

  2012cites this paper
• Expression and function of the vitamin D receptor in malignant germ cell tumour of the testis.

  2012cites this paper
• Clinical trial update and novel therapeutic approaches for metastatic prostate cancer.

  2011cites this paper
• Induction of Differentiation in Cancer Cells by Vitamin D: Recognition and Mechanisms

  2011cites this paper
• Vitamin D and Prostate Cancer

  2011cites this paper
• Suppression of prostate cancer cell rolling and adhesion to endothelium by 1α,25-dihydroxyvitamin D3.

  2011cites this paper
• Vitamin D metabolism and action in the prostate: implications for health and disease.

  2011cites this paper
• Survivin is associated with cell proliferation and has a role in 1a,25-dihydroxyvitamin D3 induced cell growth inhibition in prostate cancer.

  2011cites this paper
• Vitamin D and Cancer

  2011influential citation
• Structure-function analysis of vitamin D(2) analogs as potential inducers of leukemia differentiation and inhibitors of prostate cancer proliferation.

  2011cites this paper
• The effect of vitamin D3 and ketoconazole combination on VDR-mediated P-gp expression and function in human colon adenocarcinoma cells: implications in drug disposition and resistance.

  2011cites this paper
• Vitamin D: Cancer and differentiation

  2011cites this paper
• Vitamin D and cancer: clinical aspects.

  2011cites this paper
• Second‐line therapy for castrate‐resistant prostate cancer: A literature review

  2011cites this paper
• The Role of Vitamin D in the Prevention and Treatment of Prostate Cancer

  2011cites this paper
• Castration-Resistant Prostate Cancer: Targeted Therapies

  2011cites this paper
• 1,25‐dihydroxyvitamin D3 and PI3K/AKT inhibitors synergistically inhibit growth and induce senescence in prostate cancer cells

  2010cites this paper
• CYP24A1 inhibition enhances the antitumor activity of calcitriol.

  2010cites this paper
• Targeted therapeutic approaches for hormone-refractory prostate cancer.

  2010cites this paper
• A Phase I/II Clinical Trial of intravenous (IV) Calcitriol with fixed dose of Cisplatin and Docetaxel in Advanced Non-Small Cell Lung Cancer. Principal Investigator:

  2010cites this paper
• The role of vitamin D in cancer prevention and treatment.

  2010cites this paper
• The role of docetaxel based therapy for prostate cancer in the era of targeted medicine

  2010cites this paper
• Phytochemicals: cancer chemoprevention and suppression of tumor onset and metastasis

  2010cites this paper
• Homéostasie du fer et traitement différenciant des leucémies aigües myéloblastiques

  2010cites this paper
• Calcitriol and Vitamin D Analogs

  2010cites this paper
• Vitamin D: Considerations in the Continued Development as an Agent for Cancer Prevention and Therapy

  2010cites this paper
• Phase 2 trial of weekly intravenous 1,25 dihydroxy cholecalciferol (Calcitriol) in combination with dexamethasone for castration‐resistant prostate cancer

  2010cites this paper
• Alcohol Consumption and Risk of Colorectal Cancer

  2010cites this paper
• Molecular pathways mediating the anti-inflammatory effects of calcitriol: implications for prostate cancer chemoprevention and treatment.

  2010cites this paper
• pigenetic silencing of CYP 24 in the tumor microenvironment

  2010cites this paper
• Calcitriol enhances gemcitabine antitumor activity in vitro and in vivo by promoting apoptosis in a human pancreatic carcinoma model system

  2010cites this paper
• Serum 25-OH vitamin D levels and risk of developing prostate cancer in older men

  2010cites this paper
• Estimated benefit of increased vitamin D status in reducing the economic burden of disease in western Europe.

  2009cites this paper
• A critical review of IARC report 5 Vitamin D and cancer

  2009cites this paper
• Emerging drugs for prostate cancer

  2009cites this paper
• Survivin Is Associated With Cell Proliferation and Has a Role in 1a,25-Dihydroxyvitamin D3 Induced Cell Growth Inhibition in Prostate Cancer

  2009cites this paper